FDA Drug Application (088127) for HYDROFLUMETHIAZIDE AND RESERPINE by WATSON LABS

Back to FDA Applications sponsored by WATSON LABS

Application Number088127
Product Number001
FormTABLET;ORAL
Dosage25MG;0.125MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameHYDROFLUMETHIAZIDE AND RESERPINE
Active IngredientHYDROFLUMETHIAZIDE; RESERPINE

Active IngredientCount
List of drugs with Active Ingredient HYDROFLUMETHIAZIDE7
List of drugs with Active Ingredient RESERPINE52


Back to FDA Applications sponsored by WATSON LABS